Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Medicine, a developer and distributor of prescription and over-the-counter pharmaceuticals and medical formulations in the People's Republic of China, has signed a two-year renewable agreement with Heilongjiang Liao Yuan Technology, for exclusive provincial-level rights to distribute Nianlianping in Guangdong province, with the exception of Foshan, Zhongshan, Dongguan areas and the Guangzhou Military Hospital.
Subscribe to our email newsletter
Nianlianping is a medical macrogol berberine solution used to restrain tissue from adhering to the lesion site after surgical operation. It is widely used in the prevention of surgical adhesions, which include ascites, joint effusion, pelvic fluid and pelvic inflammatory disease. It is also used to reduce tissue fluid exudation and antibiotic usage.
Senshan Yang, chairman and CEO of China Medicine, said: “We are very excited to work together with Liao Yuan to distribute Nianlianping. With our current extensive distribution network and highly qualified sales personnel, we believe we have the competitive advantage it takes to reach our sales target for this product. We remain confident that Nianlianping will become one of China Medicine’s best selling products in coming years.”